On March 30, 2022 Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid"), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), reported that Dr. Lishan Aklog, Chairman and CEO, has been invited to present at the 21st Annual Needham Virtual Healthcare Conference taking place from April 11 – 14 (Press release, Lucid Diagnostics, MAR 30, 2022, View Source [SID1234611207]). Dr. Aklog will participate in a Fireside chat on Tuesday, April 12, from 1:30 – 2:10 pm ET. Register to listen to his presentation at View Source In addition, Lucid will host 1×1 investor meetings during the conference. Please contact your Needham representative to schedule a 1×1 meeting.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!